» Articles » PMID: 3463409

Cytotoxicity, DNA Cross-linking, and Single Strand Breaks Induced by Activated Cyclophosphamide and Acrolein in Human Leukemia Cells

Overview
Journal Cancer Res
Specialty Oncology
Date 1986 Oct 1
PMID 3463409
Citations 19
Authors
Affiliations
Soon will be listed here.
Abstract

The in vitro cytotoxicity and mechanism of action of cyclophosphamide (CP) were studied in a dual cell culture system, using rat hepatocytes and K562 human chronic myeloid leukemia cells. Cytotoxicity and DNA damage were measurable in K562 cells using CP concentrations that are clinically attainable. Alkaline elution analysis of cellular DNA demonstrated the presence of concentration- and time-dependent DNA interstrand cross-links, DNA-protein cross-links, and DNA single strand breaks in K562 cells following a 1-h exposure to cyclophosphamide activated by hepatocytes. Hepatocyte-activated CP was 3 to 4 times more potent than phosphoramide mustard with regard to cytotoxicity and induction of DNA interstrand cross-links. Exposure to phosphoramide mustard did not produce single strand breaks, but exposure of K562 cells to acrolein resulted in substantial levels of single strand breaks. The demonstration of acrolein-induced single strand breaks following exposure to activated CP is a novel finding and suggests that acrolein may have a role in the cytotoxicity of CP.

Citing Articles

ATR/Chk1 interacting lncRNA modulates DNA damage response to induce breast cancer chemoresistance.

Luo R, Wu J, Chen X, Liu Y, Liu D, Song E Cell Insight. 2024; 3(5):100183.

PMID: 39148723 PMC: 11325286. DOI: 10.1016/j.cellin.2024.100183.


KU80 is not required for the survival or activation of prophase-arrested oocytes in primordial follicles.

Ratnayaka-Gamage N, Alesi L, Zerafa N, Stringer J, Hutt K Front Endocrinol (Lausanne). 2023; 14:1268009.

PMID: 37900135 PMC: 10603181. DOI: 10.3389/fendo.2023.1268009.


Anti-Cancer Prodrug Cyclophosphamide Exerts Thrombogenic Effects on Human Venous Endothelial Cells Independent of CYP450 Activation-Relevance to Thrombosis.

Kruger-Genge A, Kohler S, Laube M, Haileka V, Lemm S, Majchrzak K Cells. 2023; 12(15).

PMID: 37566045 PMC: 10416884. DOI: 10.3390/cells12151965.


Identification of a Crosstalk among TGR5, GLIS2, and TP53 Signaling Pathways in the Control of Undifferentiated Germ Cell Homeostasis and Chemoresistance.

Thirouard L, Holota H, Monrose M, Garcia M, De Haze A, Damon-Soubeyrand C Adv Sci (Weinh). 2022; 9(17):e2200626.

PMID: 35435331 PMC: 9189661. DOI: 10.1002/advs.202200626.


Preparing for CAR T cell therapy: patient selection, bridging therapies and lymphodepletion.

Amini L, Silbert S, Maude S, Nastoupil L, Ramos C, Brentjens R Nat Rev Clin Oncol. 2022; 19(5):342-355.

PMID: 35318469 DOI: 10.1038/s41571-022-00607-3.